TY - JOUR
T1 - Identification of mis sense mutations and haplotyping of carnitine palmitoyltransferase II gene
AU - Akanuma, Jun
AU - Wataya, Kaoru
AU - Matsubara, Yoichi
AU - Kure, Shigeo
AU - Narisawa, Kuniaki
AU - Tarqni, Franco
AU - Yoshida, Ichiro
AU - Yoshino, Makoto
AU - Kira, Junichi
AU - Yamamoto, Teiji
PY - 1997
Y1 - 1997
N2 - Carnitine palmitoyltransferase II (CPTII) deficiency manifests as various clinical phenotypes: a relatively mild form with muscular symptoms and a severe phenotype presenting with hepatocardiomuscular manifestations. We have investigated three Japanese patients with CPT II deficiency. Molecular analysis revealed two novel missense mutations, a glutamate (174)-to-lyine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPTII cDNA. Transfection experiments demonstrated that the two mutations reduced CPTII catalytic activity. Case 1 (muscular form) was homozygous for the E174K mutation, whereas case 2 (hepatic form) was homozygous for the F383Y mutation. Interestingly, case 3, who was a compound hétérozygote for E174K and F383Y, exhibited hepatic symptoms. We also identified a polymorphism in the CPTII gene, a phenylalanine (352)-to-cysteine substitution (F352C). According to an expression analysis, this mutation did not alter CPTII activity. It was present in 21 out of 100 normal alleles in the Japanese population, but was not observed among Caucasians. Genotyping with this polymorphism and the p/eviously reported polymorphisms V368I and M647V allowed normal alleles to be classified into five naplotypes. In all three families, the E174K mutation resided only on F1V1M1 allele, while the F383Y mutation was observed on F2V2M1 allele, suggesting a single origin of each mutation.
AB - Carnitine palmitoyltransferase II (CPTII) deficiency manifests as various clinical phenotypes: a relatively mild form with muscular symptoms and a severe phenotype presenting with hepatocardiomuscular manifestations. We have investigated three Japanese patients with CPT II deficiency. Molecular analysis revealed two novel missense mutations, a glutamate (174)-to-lyine substitution (E174K) and a phenylalanine (383)-to-tyrosine substitution (F383Y) in the CPTII cDNA. Transfection experiments demonstrated that the two mutations reduced CPTII catalytic activity. Case 1 (muscular form) was homozygous for the E174K mutation, whereas case 2 (hepatic form) was homozygous for the F383Y mutation. Interestingly, case 3, who was a compound hétérozygote for E174K and F383Y, exhibited hepatic symptoms. We also identified a polymorphism in the CPTII gene, a phenylalanine (352)-to-cysteine substitution (F352C). According to an expression analysis, this mutation did not alter CPTII activity. It was present in 21 out of 100 normal alleles in the Japanese population, but was not observed among Caucasians. Genotyping with this polymorphism and the p/eviously reported polymorphisms V368I and M647V allowed normal alleles to be classified into five naplotypes. In all three families, the E174K mutation resided only on F1V1M1 allele, while the F383Y mutation was observed on F2V2M1 allele, suggesting a single origin of each mutation.
UR - http://www.scopus.com/inward/record.url?scp=33748142132&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748142132&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33748142132
VL - 42
SP - 101
JO - Jinrui idengaku zasshi. The Japanese journal of human genetics
JF - Jinrui idengaku zasshi. The Japanese journal of human genetics
SN - 1434-5161
IS - 1
ER -